| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.18B | 40.72B | 38.48B | 36.38B | 35.55B | 33.87B |
| Gross Profit | 9.19B | 9.40B | 8.88B | 8.49B | 8.47B | 8.18B |
| EBITDA | 5.00B | 4.95B | 4.78B | 4.58B | 4.44B | 4.32B |
| Net Income | 3.38B | 3.75B | 3.21B | 3.05B | 2.92B | 2.79B |
Balance Sheet | ||||||
| Total Assets | 49.98B | 53.24B | 52.06B | 50.84B | 48.19B | 46.85B |
| Cash, Cash Equivalents and Short-Term Investments | 23.71B | 22.87B | 24.30B | 27.13B | 24.04B | 24.20B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 6.72B | 7.90B | 8.59B | 8.98B | 8.41B | 8.73B |
| Stockholders Equity | 43.26B | 45.33B | 43.47B | 41.86B | 39.78B | 38.12B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.13B | 1.40B | 4.59B | 2.91B | 2.77B |
| Operating Cash Flow | 0.00 | 3.03B | 1.57B | 4.71B | 2.95B | 2.93B |
| Investing Cash Flow | 0.00 | -3.05B | -3.09B | -1.14B | -1.34B | -57.84M |
| Financing Cash Flow | 0.00 | -1.89B | -1.61B | -983.76M | -1.26B | -703.42M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥112.49B | 10.90 | ― | 1.02% | 23.44% | 74.38% | |
77 Outperform | ¥70.48B | 14.80 | 31.71% | 1.68% | 17.64% | 47.00% | |
74 Outperform | ¥45.91B | 12.58 | 8.02% | 2.73% | 5.82% | 16.78% | |
74 Outperform | ¥86.89B | 11.45 | ― | 2.59% | 7.79% | 9.07% | |
74 Outperform | ¥63.20B | 10.69 | ― | 2.41% | 17.21% | 35.56% | |
67 Neutral | ¥103.17B | 45.66 | ― | 0.72% | 18.27% | 189.01% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |